Clicky

Abbott Laboratories(ABT)

Description: Abbott Laboratories engages in the discovery, development, manufacture, and sale of health care products worldwide. Its Established Pharmaceutical Products segment offers branded generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, pain, fever, inflammation, hypothyroidism, gynecological disorders, intrahepatic cholestasis or depressive symptoms, physiological rhythm of the colon, dyslipidemia, and hypertension, as well as provides anti-infective and influenza vaccines. The company's Diagnostic Products segment provides diagnostic systems and tests, such as immunoassay and clinical chemistry systems; assays for screening and diagnosis for drugs of abuse, cancer, therapeutic drug monitoring, fertility, and physiological and infectious diseases; genomic-based tests; hematology systems and reagents; and diagnostic systems and tests for blood analysis, as well as instruments that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detects and measures infectious agents. Its Nutritional Products segment offers pediatric and adult nutritional products comprising various forms of prepared infant and follow-on formula. The company's Vascular Products segment provides coronary, endovascular, vessel closure, and structural heart devices for the treatment of vascular disease. Abbott Laboratories also offers blood glucose monitoring meters, test strips, and data management software and accessories for people with diabetes; and medical devices for the eye, including cataract surgery, LASIK surgery, contact lens care products, and dry eye products. The company primarily serves retailers, wholesalers, hospitals, health care facilities, laboratories, physicians' offices, and government agencies. The company was founded in 1888 and is headquartered in Abbott Park, Illinois.


Keywords: Medicine Cancer S&P 500 Life Sciences Pharmaceutical Products Pain Diabetes Infectious Diseases Inflammation Hypertension Eye Influenza Health Care Products Hematology Diagnostic Products Glucose Lipid Thyroid Nutritional Products Vascular Disease Immunoassay Cataracts Contact Lens Fertility Spas Fever Irritable Bowel Syndrome Lab Testing Blood Glucose Monitoring Diagnostic Systems Generic Pharmaceuticals Influenza Vaccine Dyslipidemia Lasik Generic Pharmaceutical Hypothyroidism Cataract Surgery Data Management Software Vascular Products Lens Care Products Gynecological Disorders Infectious Agents Lake Bluff Cholestasis Intrahepatic Cholestasis Biliary Spasm Pediatric And Adult Nutritional Products Structural Heart Devices

Home Page: www.abbott.com

ABT Technical Analysis

100 Abbott Park Road
North Chicago, IL 60064-6400
United States
Phone: 224 667 6100


Officers

Name Title
Mr. Robert B. Ford Chairman, Pres & CEO
Mr. Robert E. Funck Jr. Exec. VP of Fin. & CFO
Mr. Hubert L. Allen Exec. VP, Gen. Counsel & Sec.
Mr. Daniel Gesua Sive Salvadori Exec. VP and Group Pres of Established Pharmaceuticals & Nutritional Products
Ms. Andrea F. Wainer Exec. VP of Rapid & Molecular Diagnostics
Mr. Scott Michael Leinenweber VP of Investor Relations, Licensing & Acquisitions
James E. Young VP and Chief Ethics & Compliance Officer
Ms. Melissa Brotz VP of Public Affairs & Corp. Marketing
Ms. Elaine R. Leavenworth Sr. VP and Chief Marketing & External Affairs Officer
Ms. Mary K. Moreland Exec. VP of HR

Exchange: NYSE

Country: US : United States of America

Currency: US Dollar ($)

Forward PE: 25.1256
Trailing PE: 25.316
Price-to-Book MRQ: 5.4377
Price-to-Sales TTM: 4.2019
IPO Date: 1978-01-13
Fiscal Year End: December
Full Time Employees: 113000
Back to stocks